大连医科大学学报
大連醫科大學學報
대련의과대학학보
JOURNAL OF DALIAN MEDICAL UNIVERSITY
2014年
4期
372-375,392
,共5页
李媛媛%王红英%崔利军%桑文华%闫洪娟%李聚彩
李媛媛%王紅英%崔利軍%桑文華%閆洪娟%李聚綵
리원원%왕홍영%최리군%상문화%염홍연%리취채
阿立哌唑口崩片%精神分裂症%有效性%Meta 分析
阿立哌唑口崩片%精神分裂癥%有效性%Meta 分析
아립고서구붕편%정신분렬증%유효성%Meta 분석
brisking%schizophrenia%efficacy%Meta analyses
目的:评价阿立哌唑口崩片的有效性,为其有效使用提供借鉴。方法检索CBM、CKNI数据库,时间不限。纳入随机、半随机及临床对照试验。按Cochrane 5.0版质量评价标准评价研究质量和提取数据进行Meta分析。结果共纳入7个研究。 Meta分析显示:阿立哌唑口崩片与其他非经典抗精神病药物间疗效的差异无显著性意义[RR=1.01,95%CI(0.93,1.10),P=0.77];阿立哌唑口崩片与经典抗精神病药物间疗效的差异无显著性意义[RR=1.02,95%CI(0.95,1.09),P=0.68]。结论阿立哌唑口崩片对精神分裂症的阳性、阴性症状均有明显疗效,且副作用低,值得推广。
目的:評價阿立哌唑口崩片的有效性,為其有效使用提供藉鑒。方法檢索CBM、CKNI數據庫,時間不限。納入隨機、半隨機及臨床對照試驗。按Cochrane 5.0版質量評價標準評價研究質量和提取數據進行Meta分析。結果共納入7箇研究。 Meta分析顯示:阿立哌唑口崩片與其他非經典抗精神病藥物間療效的差異無顯著性意義[RR=1.01,95%CI(0.93,1.10),P=0.77];阿立哌唑口崩片與經典抗精神病藥物間療效的差異無顯著性意義[RR=1.02,95%CI(0.95,1.09),P=0.68]。結論阿立哌唑口崩片對精神分裂癥的暘性、陰性癥狀均有明顯療效,且副作用低,值得推廣。
목적:평개아립고서구붕편적유효성,위기유효사용제공차감。방법검색CBM、CKNI수거고,시간불한。납입수궤、반수궤급림상대조시험。안Cochrane 5.0판질량평개표준평개연구질량화제취수거진행Meta분석。결과공납입7개연구。 Meta분석현시:아립고서구붕편여기타비경전항정신병약물간료효적차이무현저성의의[RR=1.01,95%CI(0.93,1.10),P=0.77];아립고서구붕편여경전항정신병약물간료효적차이무현저성의의[RR=1.02,95%CI(0.95,1.09),P=0.68]。결론아립고서구붕편대정신분렬증적양성、음성증상균유명현료효,차부작용저,치득추엄。
Objective To systematicly evaluate the efficacy of Brisking treating Schizophrenia , providing reference for the reasonable use of this drug .Methods We searched CBM , CNKI for randomized controlled trials ( RCTs) and quasi-ran-domization controlled trials .Quality assessment and data extraction were conducted by two reviewers independently .Meta-analyses were conducted with the Cochrane Collaboration ’ s RevMan 5.0 software.Results Seven trials met the inclusion criteria.Results Showed:The effects for Schizophrenia are no significant difference between brisking and other non -clas-sical antipsychotics[RR=1.01,95%CI(0.93,1.10),P=0.77].The effects for Schizophrenia are also no significant difference between Brisking and classical -antipsychotics [RR=1.02,95%CI(0.95,1.09),P=0.68].Conclusion No significant differences were observed in the effects between brisking and other antipsychotics for Schizophrenia , We could expand its use ,especially for incipient patients and elderly patients .